US › Healthcare

Bio-Rad Laboratories Inc (BIO-B)

US · Healthcare · Medical Devices

$365.080.00%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$651.0M

Revenue YoY

-0.1%

Net profit

$371.4M

Profit YoY

+16.9%

EPS

$13.85

Net margin

57.1%

Key statistics

Market cap

$9.76B

P/E

44.5

Forward P/E

39.8

P/B

1.36

Book value

$268.30

EPS (TTM)

$8.21

52-week high

$401.59

52-week low

$244.54

50-day MA

$332.75

200-day MA

$301.28

Beta

1.07

Shareholding

Insiders

98.23%

Institutions

0.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bio-Rad Laboratories Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.